Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

2.000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
New Research Finds Gaming Can Cause Fatal Arrhythmias
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week
Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week! 
Via InvestorPlace
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Participate at Upcoming LD Micro Main Event XV Conference
Via Investor Brand Network
Frequency of Bowel Movement Could Predict Heart Attack Risk
Via Investor Brand Network
HeartBeam to Present at LD Micro Main Event XV Conference
From HeartBeam, Inc.
Via Business Wire
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. 
Via Benzinga
Study Finds Coffee Consumption Reduces Risk of Cardiac Problems
Via Investor Brand Network
How Is The Market Feeling About BioTelemetry?
BioTelemetry's (NASDAQ:BEAT) short percent of float has risen 1363.64% since its last report. The company recently reported that it has 518 thousand shares sold short, which is 8.05% of all regular... 
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Seasoned Veteran as New Chief Medical Officer
Via Investor Brand Network
HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer
From HeartBeam, Inc.
Via Business Wire
CapitalGainsReport: Sector Spotlight Medical Monitoring Stocks. (BEAT, DXCM, WHSI, NMRD, GBS)
Via AB Newswire
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... 
Via Benzinga
BioMedNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Exposures Product Safety
Beat Of Life Entertainment- A One Stop Solution For Internet Marketing
Internet marketing is the solution for business development in the digitalization era. 
Via IssueWire
Stocks Edge Lower As Bond Yields Rise
Wall Street is taking a step back, as sentiment wanes and bond yields rise. 
Via Talk Markets
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability
Via Investor Brand Network
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
Why Is HeartBeam (BEAT) Stock Up 24% Today?
HeartBeam (BEAT) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline. 
Via InvestorPlace
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
US Stocks Open Lower; Dow Drops Over 200 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Thursday. 
Via Benzinga
HeartBeam (NASDAQ: BEAT) Unveils Cardiac Wearable Connectivity Feature that Can Turn Smartwatch Devices into Around-the-Clock Heart Monitoring Solutions
HeartBeam, Inc. (NASDAQ: BEAT) is engaged as a cardiac technology company, which leverages its line of proprietary algorithms to help 
Via Spotlight Growth
Topics Intellectual Property
Exposures Intellectual Property
Why Heartbeam Stock Is Surging Today
Heartbeam Inc (NASDAQ: BEAT) shares are surging Thursday morning after the company announced it expanded its product portfolio pipeline to include smartwatch connectivity, which will serve the growing... 
Via Benzinga
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
HeartBeam, Inc. (NASDAQ: BEAT) Featured in Virtual Coverage of Dawson James Small Cap Growth Conference on October 12th
Via Investor Brand Network
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. 
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Announces Participation in Two Investor Events
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.